ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-PO966

Ambulatory Palliative Care (PC) in Advanced CKD

Session Information

Category: CKD (Non-Dialysis)

  • 2302 CKD (Non-Dialysis): Clinical, Outcomes, and Trials

Authors

  • Ravipati, Prasanti S., Tufts Medical Center, Boston, Massachusetts, United States
  • Buss, Mary Kathleen, Tufts Medical Center, Boston, Massachusetts, United States
  • Gilbert, Scott J., Tufts Medical Center, Boston, Massachusetts, United States
Background

Under 10% of patients on dialysis discuss goals, values, and preferences with their nephrologist; nearly 90% want to. PC can enhance patient quality of life, improve illness understanding and alter decisions at end of life. Global ambulatory renal PC clinics have been successful but are rare in the US.

We tested the feasibility of integrating ambulatory PC for patients with CKD via manual EMR screening.

Methods

Renal and PC developed screening criteria:
1. Age >70 w/ stage 5 CKD
2. Age >70 w/ stage 4 CKD and cardiovascular disease or diabetes
3. Age >80 w/ stage 4 CKD

For 11 weeks, study staff used the EMR to screen patients scheduled in renal clinic. A list of patients who met criteria were emailed to renal providers. If deemed appropriate, renal introduced PC to the patient. If the patient agreed, a PC referral was placed. PC saw referred patients before or after their renal clinic visit in the same room.

Results

See Fig 1. Renal agreed 33% of patients who met criteria were PC appropriate. Of patients who met criteria, 19% were seen by PC (Fig 2). PC saw significantly more patients in the 3 months after the intervention (n= 22), compared to before the intervention (n = 3), [X2 = 14.3; p <0.001].

Conclusion

Our study showed the feasibility of using screening criteria to integrate PC into renal clinic for advanced CKD patients. The higher volume seen by PC suggests the process helped renal providers identify patients appropriate for PC. Manual screening was resource intensive. An automated EMR screen would be more sustainable.

The continued increase in PC visits after the study suggests a change in practice and improved access to PC. Our model for an integrated renal PC clinic promotes patient centered quality care for patients with advanced CKD.